Condition
Hepatic Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Hepatic Cancer clinical trials that are recruiting, at sites in 4 countries (most in United States (3), China (2), Italy (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Hepatic Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Dose-finding of EXS74539 (REC-4539) in select solid tumors | Phase 1 | Los Angeles, California and 2 other locations | Recruiting | Apr 8, 2026 |
| Evaluating pain management methods for minimally invasive cancer surgery | — | Pittsburgh, Pennsylvania | Recruiting | Dec 13, 2024 |
| Algorithm for diagnosing liver cancer mutations | — | Bologna | Recruiting | Dec 5, 2024 |
| Evaluating PSMA PET/CT Imaging for Prostate Cancer Patients | — | Hefei, Anhui and 2 other locations | Recruiting | Nov 15, 2024 |
| Neoadjuvant immunotherapy for liver cancer | Phase 2 | Guanzhou, Guangdong | Recruiting | Jul 9, 2024 |
| Liquid biopsy to differentiate types of primary liver cancer | — | Duarte, California and 4 other locations | Recruiting | Apr 2, 2024 |
All recruiting trials (6)
-
Dose-finding of EXS74539 (REC-4539) in select solid tumors
This study will try different doses of the experimental drug EXS74539 in adults with select solid tumors to find a safe and tolerable dose.
-
Evaluating pain management methods for minimally invasive cancer surgery
This study is testing which pain management method works best for people undergoing minimally invasive cancer surgery by comparing three different approaches.
-
Algorithm for diagnosing liver cancer mutations
This study is testing a new way to identify specific mutations in liver cancer to help doctors make better treatment decisions for patients before surgery.
-
Evaluating PSMA PET/CT Imaging for Prostate Cancer Patients
This study is testing a special type of imaging called PSMA PET/CT to see if it can help find cancer in adults who have or might have prostate cancer.
-
Neoadjuvant immunotherapy for liver cancer
This study is testing a new way to deliver immunotherapy directly into liver tumors to see if it helps patients with liver cancer feel better and have better treatment results before surgery.
-
Liquid biopsy to differentiate types of primary liver cancer
This study is testing a new blood test to see if it can tell the difference between two types of liver cancer, hepatocellular carcinoma and intrahepatic cholangiocarcinoma, to help doctors diagnose patients more safely.
Related topics
Quick answers
How many Hepatic Cancer clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (3 trials), China (2 trials), Italy (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.